Table 6. Logistic regression OR for sex, disease duration and age at diagnosis in 750 patients with type 1 diabetes.
| β | SE | OR (95% CI) | P | |
|---|---|---|---|---|
| GADA | ||||
| Females | 0.57 | 0.16 | 1.77 (1.28–2.44) | <0.0005 |
| Disease duration (year) | –0.19 | 0.03 | 0.83 (0.78–0.88) | <0.0001 |
| Age at diagnosis (year) | –0.03 | 0.02 | 1.03 (0.99–1.07) | 0.20 |
| IA2A | ||||
| Females | 0.014 | 0.16 | 0.99 (0.71–1.36) | 0.93 |
| Disease duration (year) | –0.27 | 0.03 | 0.76 (0.72–0.82) | <0.0001 |
| Age at diagnosis (year) | –0.03 | 0.02 | 0.97 (0.93–1.01) | 0.10 |
| GADA or IA2A | ||||
| Females | 0.57 | 0.21 | 1.76 (1.16–2.68) | 0.008 |
| Disease duration (year) | –0.26 | 0.03 | 0.77 (0.73–0.82) | <0.0001 |
| Age at diagnosis (year) | –0.04 | 0.03 | 0.97 (0.93–1.03) | 0.32 |
Abbreviations: GADA, Glutamic acid decarboxylase 65 autoantibody; IA2A, insulinoma-associated protein 2 autoantibody; OR, odds ratio; SE, standard error.